CheekAge: Next-gen epigenetic clock accurately predicts mortality risk

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Researchers developed CheekAge, an epigenetic clock based on buccal cells, and found it predicted mortality risk with significant accuracy. This study validates CheekAge as a reliable aging biomarker, outperforming first-generation clocks.